Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13


Hypoxia-Targeting Drug Evofosfamide (TH-302) Enhances Sunitinib Activity in Neuroblastoma Xenograft Models.

Kumar S, Sun JD, Zhang L, Mokhtari RB, Wu B, Meng F, Liu Q, Bhupathi D, Wang Y, Yeger H, Hart C, Baruchel S.

Transl Oncol. 2018 Aug;11(4):911-919. doi: 10.1016/j.tranon.2018.05.004. Epub 2018 May 31.


Erratum to: The role of Sulforaphane in cancer chemoprevention and health benefits: a mini-review.

Mokhtari RB, Baluch N, Homayouni TS, Morgatskaya E, Kumar S, Kazemi P, Yeger H.

J Cell Commun Signal. 2018 Jun;12(2):503. doi: 10.1007/s12079-017-0408-4. No abstract available.


Simultaneous Targeting of Bladder Tumor Growth, Survival, and Epithelial-to-Mesenchymal Transition with a Novel Therapeutic Combination of Acetazolamide (AZ) and Sulforaphane (SFN).

Islam SS, Mokhtari RB, Akbari P, Hatina J, Yeger H, Farhat WA.

Target Oncol. 2016 Apr;11(2):209-27. doi: 10.1007/s11523-015-0386-5.


Sonic hedgehog (Shh) signaling promotes tumorigenicity and stemness via activation of epithelial-to-mesenchymal transition (EMT) in bladder cancer.

Islam SS, Mokhtari RB, Noman AS, Uddin M, Rahman MZ, Azadi MA, Zlotta A, van der Kwast T, Yeger H, Farhat WA.

Mol Carcinog. 2016 May;55(5):537-51. doi: 10.1002/mc.22300. Epub 2015 Mar 1.


Carbonic anhydrase II mediates malignant behavior of pulmonary neuroendocrine tumors.

Zhou Y, Mokhtari RB, Pan J, Cutz E, Yeger H.

Am J Respir Cell Mol Biol. 2015 Feb;52(2):183-92. doi: 10.1165/rcmb.2014-0054OC.


Manganese-enhanced MRI of minimally gadolinium-enhancing breast tumors.

Ganesh T, Mokhtari RB, Alhamami M, Yeger H, Cheng HL.

J Magn Reson Imaging. 2015 Mar;41(3):806-13. doi: 10.1002/jmri.24608. Epub 2014 Mar 4.


TGF-β1 induces EMT reprogramming of porcine bladder urothelial cells into collagen producing fibroblasts-like cells in a Smad2/Smad3-dependent manner.

Islam SS, Mokhtari RB, El Hout Y, Azadi MA, Alauddin M, Yeger H, Farhat WA.

J Cell Commun Signal. 2014 Mar;8(1):39-58. doi: 10.1007/s12079-013-0216-4. Epub 2013 Dec 12.


Combination of carbonic anhydrase inhibitor, acetazolamide, and sulforaphane, reduces the viability and growth of bronchial carcinoid cell lines.

Mokhtari RB, Kumar S, Islam SS, Yazdanpanah M, Adeli K, Cutz E, Yeger H.

BMC Cancer. 2013 Aug 8;13:378. doi: 10.1186/1471-2407-13-378.


Tumor dynamics in response to antiangiogenic therapy with oral metronomic topotecan and pazopanib in neuroblastoma xenografts.

Kumar S, Mokhtari RB, Oliveira ID, Islam S, Toledo SR, Yeger H, Baruchel S.

Transl Oncol. 2013 Aug 1;6(4):493-503. Print 2013 Aug.


Spatio-temporal distribution of Smads and role of Smads/TGF-β/BMP-4 in the regulation of mouse bladder organogenesis.

Islam SS, Mokhtari RB, Kumar S, Maalouf J, Arab S, Yeger H, Farhat WA.

PLoS One. 2013 Apr 19;8(4):e61340. doi: 10.1371/journal.pone.0061340. Print 2013.


Preclinical models for pediatric solid tumor drug discovery: current trends, challenges and the scopes for improvement.

Kumar S, Mokhtari RB, Yeger H, Baruchel S.

Expert Opin Drug Discov. 2012 Nov;7(11):1093-106. doi: 10.1517/17460441.2012.722077. Epub 2012 Sep 24. Review.


Metronomic oral topotecan with pazopanib is an active antiangiogenic regimen in mouse models of aggressive pediatric solid tumor.

Kumar S, Mokhtari RB, Sheikh R, Wu B, Zhang L, Xu P, Man S, Oliveira ID, Yeger H, Kerbel RS, Baruchel S.

Clin Cancer Res. 2011 Sep 1;17(17):5656-67. doi: 10.1158/1078-0432.CCR-11-0078. Epub 2011 Jul 25.


Circulating endothelial cells and circulating endothelial precursor cells in patients with osteosarcoma.

DuBois SG, Stempak D, Wu B, Mokhtari RB, Nayar R, Janeway KA, Goldsby R, Grier HE, Baruchel S.

Pediatr Blood Cancer. 2012 Feb;58(2):181-4. doi: 10.1002/pbc.23046. Epub 2011 Feb 11.

Supplemental Content

Loading ...
Support Center